Boehringer Ingelheim Secures US FDA’s EUA for NexGard and NexGard COMBO to Treat NWS

Shots: The US FDA has granted Emergency Use Authorization (EUA) for NexGard (afoxolaner) chewables for treating infestations caused by New World screwworm (NWS) in dogs and puppies, and NexGard COMBO topical solution for treating infestations caused by NWS in cats and kittens NexGard (afoxolaner) is approved for dogs only and is safe for puppies 8…

ByDipanshu DixitFebruary 20, 2026

INSIGHTS+

Insights+: The US FDA New Drug Approvals in July 2023

Shots: The US FDA approved 5 NDAs and 2 BLA in July 2023, leading to treatments for patients and advances in the healthcare industry. The CDER and CBER approved 76 novel products in 2023 In July 2023, the major highlights drugs were Beyfortus (nirsevimab) approval for the prevention of RSV lower respiratory tract disease in…

BySenior EditorAugust 16, 2023

Boehringer Ingelheim Secures US FDA’s EUA for NexGard and NexGard COMBO to Treat NWS

Insights+: The US FDA New Drug Approvals in July 2023

Contact US

FOLLOW US